Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M.A. Abdel-Fatah, Srinivasan Madhusudan, Fiona K. Middleton et al.|Molecular Oncology|2014Cited by 84
Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Srinivasan Madhusudan, Paul M. Moseley et al.|Molecular Oncology|2014Cited by 80
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast CancerArvind Arora, Srinivasan Madhusudan, Tarek M. Abdel-Fatah et al.|Molecular Cancer Therapeutics|2015Cited by 53
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancerNouf H. Alsubhi, Srinivasan Madhusudan, Fiona K. Middleton et al.|Molecular Oncology|2015Cited by 42
Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large CohortsTarek M. Abdel-Fatah, Srinivasan Madhusudan, Arvind Arora et al.|Neoplasia|2014Cited by 41